ACI submits tox data to FSA
The Association for the Cannabinoid Industry (ACI) submitted a complete toxicological package to the Food Standards Agency (FSA) on Friday, 4 November 2022, to support members’ novel food applications. These applications account for 33% of the applications made to the FSA, and align to approximately half of the products identified on the public list. Currently […]
EFSA reveals several areas of concern in novel food applications
The European Food Safety Authority (EFSA) has found several key areas of concern in novel food submissions it has received for CBD. Among the areas of primary concern are missing information on applications and data gaps, which would support the evaluation of safety profiles, according to information shared during an EFSA-led webinar on 29 June. […]
Experts in botanical ingredients turn their attention to cannabinoids
It’s not often you come across a company in the CBD world that has four decades of history. Susanne Caspar, Chief Executive of Linnea talks about succeeding in the botanical ingredients business and opening the doors to cannabinoids. Located in Switzerland, Linnea has been delivering botanical ingredients to the pharmaceutical, food and cosmetic industries across […]
The UK’s CBD list is here. What happens next?
The long awaited list of ingestible CBD products permitted for sale was published on 31 March 2022. A total of 3,536 products linked to 70 applications have been given the green light to remain on the market by the Food Standards Agency, however the majority are awaiting the outcome of further evidence. This means making […]
Review of UK public policy and regulatory stewardship of the legal cannabis industry announced
The Centre for Medicinal Cannabis, the Association for the Cannabinoid Industry and the First November Group have today announced the launch the Hodges Review – a new, wide ranging commission to assess regulation and public policy relating to the UK’s legal cannabis industry. The review will be led by Professor Christopher Hodges, Emeritus Professor of […]
Can CBD put a pin in hair loss? We asked a scientist
Finding an effective cure for baldness or hair loss has always been a hot topic of study. Following a growing interest in cannabis-based products for hair loss, we asked Isabel Litwin-Davies, senior researcher at Britannia Life Sciences to investigate. According to the US National Library of Medicine, more than 50% of men over the age […]
Everything you need to know about CBD vapes
Updated 30.08.2022 Vaping has enjoyed a rise in popularity in the UK in recent years. There are now an estimated 4.3 million British adults who vape, with many taking up the habit as a means to quit smoking. New data from Action on Smoking and Health (ASH), suggests 8.3% of adults in England, Wales and Scotland vape […]
UK CBD sector on standby for release of FSA’s list of permitted products
The UK’s consumer health sector is set for its biggest shake-up in more than a decade when the Food Standards Agency (FSA) releases its eagerly-awaited public list of CBD products permitted for sale to consumers. Only products on the list will be able to stay on the market, while those not included will have to […]
FSA issues clarification and new deadline for toxicology data
A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products. Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]
How safe is CBD?
Widely available in an array of formats across the wellness category, the rise of this hemp extract in consumer products begs the question – how safe is CBD? Years of consumption of CBD have provided a wealth of information about safety. – Toxicology expert, Dr Paul Duffy Skincare and cosmetics When it comes to applying […]